Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I

• Balakumar Chandrasekaran,
• Muthupandian Saravanan

Affiliations

Balakumar Chandrasekaran

Department of Pharmaceutical Chemistry, School of Pharmacy, ITM-University, Gwalior, India

Muthupandian Saravanan

AMR and Nanotherapeutics Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India